From Wikipedia, the free encyclopedia
|Source||Humanized (from mouse)|
|Molar mass||145.4 kg/mol|
|(what is this?)|
Anrukinzumab was developed by Wyeth.
- "Wyeth.com | Complete Project Listing". Wyeth. 2008. Archived from the original on June 12, 2008. Retrieved November 19, 2008.
- Statement On A Nonproprietary Name Adopted By The USAN Council: Anrukinzumab, American Medical Association.
|This monoclonal antibody-related article is a stub. You can help Wikipedia by expanding it.|